A portable and cost-effective device that delivers consistently high levels of oxygen to Covid-19 patients and helps keep their lungs from collapsing has been approved by the South African Health Products Regulatory Authority (Sahpra). OxERA oxygen supply deviceThe OxERA (oxygen-efficient respiratory aid), is effective where there are a large number of Covid-19 patients yet a lack of skilled staff, ICU and high care facilities; and insufficient bulk oxygen supplies. It effectively bridges the gap between current standard oxygen therapy via face masks and ICU-based non-invasive or mechanical ventilation, while requiring no more oxygen flow than a standard face mask. The device was developed by a group of East London-based volunteers that includes doctors, engineers and entrepreneurs. The has now approved the OxERA device for emergency Covid-19 use, which will be manufactured and distributed by Gabler Medical.